Works matching IS 09509232 AND DT 2009 AND VI 28 AND IP 45

Results: 8

Impaired PTPN13 phosphatase activity in spontaneous or HPV-induced squamous cell carcinomas potentiates oncogene signaling through the MAP kinase pathway.
Published in:
Oncogene, 2009, v. 28, n. 45, p. 3960, doi. 10.1038/onc.2009.251
By:
- Hoover, A. C.;
- Strand, G. L.;
- Nowicki, P. N.;
- Anderson, M. E.;
- Vermeer, P. D.;
- Klingelhutz, A. J.;
- Bossler, A. D.;
- Pottala, J. V.;
- Hendriks, W. J. A. J.;
- Lee, J. H.
Publication type:
Article
Hepatic tumor–stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge.
Published in:
Oncogene, 2009, v. 28, n. 45, p. 4022, doi. 10.1038/onc.2009.253
By:
- van Zijl, F.;
- Mair, M.;
- Csiszar, A.;
- Schneller, D.;
- Zulehner, G.;
- Huber, H.;
- Eferl, R.;
- Beug, H.;
- Dolznig, H.;
- Mikulits, W.
Publication type:
Article
Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell death.
Published in:
Oncogene, 2009, v. 28, n. 45, p. 4009, doi. 10.1038/onc.2009.250
By:
- Tennant, D. A.;
- Frezza, C.;
- MacKenzie, E. D.;
- Nguyen, Q. D.;
- Zheng, L.;
- Selak, M. A.;
- Roberts, D. L.;
- Dive, C.;
- Watson, D. G.;
- Aboagye, E. O.;
- Gottlieb, E.
Publication type:
Article
Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α.
Published in:
Oncogene, 2009, v. 28, n. 45, p. 3949, doi. 10.1038/onc.2009.252
By:
- Soeda, A.;
- Park, M.;
- Lee, D.;
- Mintz, A.;
- Androutsellis-Theotokis, A.;
- McKay, R. D.;
- Engh, J.;
- Iwama, T.;
- Kunisada, T.;
- Kassam, A. B.;
- Pollack, I. F.;
- Park, D. M.
Publication type:
Article
Leupaxin acts as a mediator in prostate carcinoma progression through deregulation of p120catenin expression.
Published in:
Oncogene, 2009, v. 28, n. 45, p. 3971, doi. 10.1038/onc.2009.254
By:
- Kaulfuß, S.;
- von Hardenberg, S.;
- Schweyer, S.;
- Herr, A. M.;
- Laccone, F.;
- Wolf, S.;
- Burfeind, P.
Publication type:
Article
A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes.
Published in:
Oncogene, 2009, v. 28, n. 45, p. 4034, doi. 10.1038/onc.2009.255
By:
- Careccia, S.;
- Mainardi, S.;
- Pelosi, A.;
- Gurtner, A.;
- Diverio, D.;
- Riccioni, R.;
- Testa, U.;
- Pelosi, E.;
- Piaggio, G.;
- Sacchi, A.;
- Lavorgna, S.;
- Lo-Coco, F.;
- Blandino, G.;
- Levrero, M.;
- Rizzo, M. G.
Publication type:
Article
Three Epstein–Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints.
Published in:
Oncogene, 2009, v. 28, n. 45, p. 3997, doi. 10.1038/onc.2009.258
By:
- Gruhne, B.;
- Sompallae, R.;
- Masucci, M. G.
Publication type:
Article
Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2).
Published in:
Oncogene, 2009, v. 28, n. 45, p. 3983, doi. 10.1038/onc.2009.264
By:
- Arlt, A.;
- Bauer, I.;
- Schafmayer, C.;
- Tepel, J.;
- Müerköster, S. Sebens;
- Brosch, M.;
- Röder, C.;
- Kalthoff, H.;
- Hampe, J.;
- Moyer, M. P.;
- Fölsch, U. R.;
- Schäfer, H.
Publication type:
Article